June 16, 2023 /

Webinar: ENVISION Study Update with Sarepta Therapeutics

by: Parent Project Muscular Dystrophy

Sarepta’s Medical Director, Clinical Development discusses the company’s upcoming ENVISION study for SRP-9001.

Research & Clinical Trial Webinars,

2 years ago

You may also like

Webinar: Sarepta Therapeutics - Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne

Webinar: Sarepta Therapeutics – Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne

5 days ago

Research & Clinical Trial Webinars,

Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne

Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne

2 weeks ago

Research & Clinical Trial Webinars,

dyne therapeutics,

Webinar: Steroids and Stress Dosing - Understanding the Updated PJ Nicholoff Steroid Protocol

Webinar: Steroids and Stress Dosing – Understanding the Updated PJ Nicholoff Steroid Protocol

3 weeks ago

emergency care,

Webinar: Discover the Power of Your Data - The Duchenne Registry

Webinar: Discover the Power of Your Data – The Duchenne Registry

1 month ago

The Duchenne Registry

Webinar: Sarepta Therapeutics - Duchenne Gene Therapy Update

Webinar: Sarepta Therapeutics – Duchenne Gene Therapy Update

2 months ago

Research & Clinical Trial Webinars,

Webinar: Duchenne Newborn Screening - Next Steps Following ACHDNC Dissolution

Webinar: Duchenne Newborn Screening – Next Steps Following ACHDNC Dissolution

2 months ago

newborn screening

Webinar: Wave Life Sciences - Update on FORWARD-53 Study of WVE-N531

Webinar: Wave Life Sciences – Update on FORWARD-53 Study of WVE-N531

3 months ago

Research & Clinical Trial Webinars,

wave life sciences,

Webinar: Avidity Biosciences - Topline Data from EXPLORE44® Clinical Trial

Webinar: Avidity Biosciences – Topline Data from EXPLORE44® Clinical Trial

3 months ago

Research & Clinical Trial Webinars,

avidity biosciences,

12 3…27 »

Page 1 of 27

Join Our Mailing List